Knee and Joint Pain Treatment in Houston: A Physician-Led Approach
Medical oversight: Micah Craig, MD, Medical Director, Valere Regenerative
Knee pain that keeps coming back usually has more than one cause, so it needs more than one fix. At Valere, care starts with a 45-minute physician-led assessment, then a program built around the activities you want to keep doing.
What usually drives it
The most common cause of long-running knee pain in adults is osteoarthritis, the gradual wear of cartilage and change in the joint around it. It affects about 32.5 million US adults (OA Action Alliance). Tendon problems, old injuries, weak supporting muscles, body weight and how you train all add to it.
That is why the same diagnosis can feel very different from one person to the next. A plan that works has to account for your joint, your strength, your weight and your goals together.
The standard options
The American College of Rheumatology and Arthritis Foundation guideline strongly recommends exercise, weight loss when appropriate, self-management programs, tai chi, NSAIDs and, for flare-ups, steroid injections (guideline summary). Surgery, including joint replacement, is the right answer for some people. These options work best as part of a plan, not one at a time over years.
How Valere approaches knee and joint pain
Every patient is assessed first. There is no menu of standard packages. Depending on what the assessment finds, your program can include:
A mobility program: strength and movement work planned around your activity goals, progressed as you build, with regular testing so you can see your progress.
StemWave® focused acoustic wave therapy: sessions of about 10 to 15 minutes with no needles and no downtime, aimed at the tendon and soft tissue around the joint.
Exosome therapy or Wharton's jelly for orthopedic cases: delivered under ultrasound guidance when the assessment supports it. Both are investigational biologics and are not FDA approved for any orthopedic condition; your physician will explain what is and is not known before you decide.
Hormones, nutrition and weight: reviewed as part of the program, because they affect muscle, recovery and the load on your joints.
What to expect
Assessment: a 45-minute conversation about your history, what you have tried and what you want to get back to.
Your plan: which parts fit, in what order, and what happens next. No pressure to commit.
Follow-up: regular check-ins and testing against your starting point, with the plan adjusted as you go.
What it costs
The assessment is $89. Program pricing follows it, because no two plans are the same. Cost depends on which parts your plan includes, how many sessions it needs and how often you are seen. For reference, exosome therapy for orthopedic cases, which is investigational, typically starts at $2,250, depending on the case. Valere does not accept insurance; financing is available through Cherry and CareCredit.
Common questions
Do I need imaging before my assessment? No. Bring any X-rays or MRI reports you already have; your physician will tell you if more is needed.
Can I keep training? In most cases, yes. Movement is part of every mobility program, planned around what your knee currently supports.
Is this a replacement for surgery? Not always. For some people surgery is the right choice, and the assessment is an honest place to find out.
Are exosomes and Wharton's jelly FDA approved? No. Both are investigational biologics, and the FDA has not approved any exosome or Wharton's jelly product for orthopedic conditions (FDA). Before you decide, your physician will explain what the research does and does not show, the possible risks, and the standard alternatives. Results vary, and no outcome is guaranteed.
Does insurance cover it? Valere does not accept insurance; programs are self-pay. Financing is available through Cherry and CareCredit.
Further reading: How to keep playing golf with knee pain and non-surgical joint treatment in Houston.
Reserve your assessment or call (713) 538-1203.
Candidacy for any program is determined by physician evaluation. Regenerative and cellular services, including exosomes and Wharton's jelly, are investigational and not FDA approved to diagnose, treat, cure or prevent any disease. Individual results vary.
Medical disclaimer: This article is for general education only and is not medical advice. Reading it does not create a doctor–patient relationship. The treatments discussed are not right for everyone, individual results vary and are not guaranteed, and some therapies mentioned may be used off-label or are not FDA-approved for the uses described. Please talk with a licensed physician about your own health before starting any treatment.
